Inventor
HIRST GAVIN C
US18 patents
⚠️ This page may combine multiple inventors who share the name “HIRST GAVIN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
7 patentsUS6921763B2Jul 26, 2005
Pyrazolopyrimidines as therapeutic agents
ABBOTT LAB275 citations98
US7863444B2Jan 4, 2011
4-aminopyrrolopyrimidines as kinase inhibitors
ABBOTT LAB31 citations89
US7829570B2Nov 9, 2010
Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
ABBOTT LAB14 citations83
US7709468B2May 4, 2010
Imidazo based heterocycles
ABBOTT LAB15 citations82
US7202363B2Apr 10, 2007
Thienopyridine and furopyridine kinase inhibitors
ABBOTT LAB12 citations82
US7737160B2Jun 15, 2010
Thienopyridine and furopyridine kinase inhibitors
ABBOTT LAB2 citations60
US7400979B2Jul 15, 2008
Method of identifying inhibitors of Lck
ABBOTT LAB1 citations49
JANSSEN PHARMACEUTICA NV
4 patentsUS10947252B2Mar 16, 2021
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV3 citations71
US11897900B2Feb 13, 2024
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US11427601B1Aug 30, 2022
Inhibitors of KEAP1-Nrf2 protein-protein interaction
JANSSEN PHARMACEUTICA NV0 citations60
US12516038B2Jan 6, 2026
Inhibitors of antigen presentation by HLA-DR
JANSSEN PHARMACEUTICA NV0 citations44